Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acer Therapeutics Inc (NASDAQ:ACER)

19.35
Delayed Data
As of Oct 16
 +0.25 / +1.31%
Today’s Change
5.18
Today|||52-Week Range
39.35
+103.11%
Year-to-Date
No recent news for Acer Therapeutics Inc.

Today’s Trading

Previous close19.10
Today’s open19.10
Day’s range18.26 - 19.35
Volume30,300
Average volume (3 months)44,889
Market cap$14.1M
Dividend yield--
Data as of 10/16/2017

Growth & Valuation

Earnings growth (last year)+44.88%
Earnings growth (this year)+58.41%
Earnings growth (next 5 years)--
Revenue growth (last year)+13.65%
P/E ratioNM
Price/Sales2.23
Price/Book4.87

Competitors

 Today’s
change
Today’s
% change
MBVXMabVax Therapeutics ...-0.04-4.93%
CPHIChina Pharma Holding...+0.00+0.94%
SSKNSTRATA Skin Sciences...0.000.00%
NEOTNeothetics Inc-0.02-3.81%
Data as of 10/16/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$1.24
Annual revenue (last year)$2.9M
Annual profit (last year)-$8.0M
Net profit margin-274.69%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Christopher Schelling
Chief Financial Officer
Harry S. Palmin
Corporate headquarters
Cambridge, Massachusetts

Forecasts